← All diseases Cancer

Hodgkin lymphoma

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchStrongest evidence only (57)Meta-analysis (20)Treatment guideline (1)Systematic review (22)Phase 3 study (8)Randomized trial (6)Clinical trial (606)Review article (177)Early study (phase 1 or 2) (49)Case report (347)Laboratory or animal study (10)Commentary or editorial (20) Studies currently recruiting participants only (49)

Filter

Publications and studies (1992)

• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Vallecular Large B-Cell Lymphoma: An Uncommon Presentation of Follicular-Origin Disease. (2026/06/27) ♡
• The Association Between Potential Nuclear Factor-Kappa B1 Gene Polymorphism rs28362491 and miR-206 Level in Patients With Acute Lymphoblastic Leukemia. (2026/06/25) ♡
• Marginal zone lymphoma is associated with dysregulated T-cell immunity that is not altered by ibrutinib-venetoclax treatment. (2026/06/25) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Fatal Acute Liver Failure Associated With Presumed Hepatitis B Virus Reactivation During Rituximab Maintenance Therapy: A Case Report. (2026/06/24) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System and Systemic Classic Hodgkin Lymphoma in the Same Patient. (2026/06/20) ♡
• Comparative Prognostic Performance of Nutritional and Inflammatory Indices in Diffuse Large B-Cell Lymphoma. (2026/06/17) ♡
• Low T3 syndrome in children with aggressive mature B-cell non-Hodgkin lymphoma. (2026/06/15) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Multifunctional CD38 in the pathogenesis and treatment of B-cell lymphomas. (2026/06/15) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Ulcerative gastric MALT lymphoma with marked eosinophilic infiltration: a case report. (2026/06/15) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Anti-mGluR5 encephalitis: distinctive clinical features and antibody patterns in the Chinese population. (2026/06/15) ♡
• Gastrointestinal toxicity in the treatment of hematological tumors. Influence on nutritional status. (2026/06/15) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Systemic Glucocorticoid Use and Risk of Site-Specific Cancers: A Methodologic Systematic Review of Observational Studies. (2026/06/02) ♡
• Associations of smoking with the risk of second smoking-associated primary cancer among adults with a history of cancer. (2026/06/01) ♡
• Clinical Characteristics and Survival Analysis of Pediatric Non-Hodgkin Lymphoma in Fujian Province. (2026/06/01) ♡
• Systemic inflammatory burden at diagnosis predicts survival in Hodgkin lymphoma: a comprehensive evaluation of the Complete Blood Count Score Model. (2026/06/01) ♡
• Nivolumab-AVD versus Brentuximab Vedotin-AVD as First-Line Treatment for Advanced-Stage Classical Hodgkin Lymphoma: A Cost-Effectiveness Analysis. (2026/05/19) ♡
• The global landscape of non-Hodgkin lymphoma incidence and mortality in 2022 and projections to 2045. (2026/05/11) ♡
• Pre-Transplant Prognostic Nutritional Index Independently Predicts Progression-Free Survival After Autologous Stem Cell Transplantation in Lymphoma. (2026/05/06) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Experience with Anthracycline Free Intensive Regimen BE_CODD for Managing a Case of Advanced Classical Hodgkin Lymphoma (CHL). (2026/05/01) ♡
• Outcomes of Brentuximab Vedotin Monotherapy in Refractory/Relapsed Classical Hodgkin's Lymphoma: A Multi-Center Retrospective Study on Survival and Safety. (2026/05/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The New Insight on the Significance of Vascular Endothelial Growth Factor in Anti-angiogenesis Therapy for Diffuse Large B Cell Lymphoma. (2026/05/01) ♡
• Outcome of Non-Hodgkin's Lymphoma in Adults-Real World Experience from a Cancer Centre in North-East India. (2026/05/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Lytic Lesion of the Scapula Masquerading as Sarcoma: A Rare Manifestation of Diffuse Large B-Cell Lymphoma. (2026/05/01) ♡
• Addition of Low Dose Nivolumab to Salvage Chemotherapy in Patients with Relapsed/Refractory Hodgkin Lymphoma. (2026/05/01) ♡
• Frequency and Distribution of Lymphomas in Northwestern India: A Retrospective Analysis of 923 Cases Using the Latest World Health Organization Classification 5(th) Edition. (2026/05/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Non-Hodgkin lymphoma arising in a vallecular cyst: A rare clinical entity. (2026/05/01) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Dietary fat consumption and cancer outcomes: an umbrella review of systematic reviews and meta-analyses. (2026/05/01) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Vegetarian and vegan diets and cancer incidence: a systematic review and meta-analysis of prospective studies. (2026/05/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Exploiting ALK inhibition in anaplastic large cell lymphoma: Biological rationale and therapeutic integration. (2026/05/01) ♡
• Divergent roles of skeletal muscle 11β-HSD1 in age-related and chronic kidney disease-associated sarcopenia. (2026/04/30) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Nontranslocation follicular lymphoma mimicking infectious mononucleosis: a diagnostic challenge in a 39-year-old male. (2026/04/28) ♡
• Serum-free production of anti-huCD20(hγ1)-IL2no-alpha immunocytokine: a promising therapeutic for B-NHL. (2026/04/15) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Agent-specific, histopathology-stratified hematologic malignancy risk among dpp-4 inhibitors, glp-1 receptor agonists, and SGLT2 inhibitors: a network meta-analysis of 270,471 participants. (2026/04/09) ♡
• Hodgkin lymphoma of the ampulla of Vater: A rare cause of obstructive jaundice in children. (2026/04/07) ♡
• HIV, HBV, and HCV Testing in Newly Diagnosed Diffuse Large B-Cell Lymphoma: Experience From a Comprehensive Cancer Center. (2026/04/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Beyond PD-1: Mechanisms of Resistance to Checkpoint Blockade in Classical Hodgkin Lymphoma and Next-Generation Immune Strategies. (2026/04/01) ♡
• Individualized physical activity program for older adults undergoing chemotherapy for hematologic malignancies. (2026/04/01) ♡
• Vegetarian diets and cancer risk: pooled analysis of 1.8 million women and men in nine prospective studies on three continents. (2026/04/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. The great masquerader: primary vitreoretinal lymphoma presenting as white dot syndrome. (2026/04/01) ♡
• Palliative total kidney irradiation for acute kidney injury caused by bilateral renal infiltration of chemotherapy-resistant mantle cell lymphoma: a case report. (2026/03/27) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Prognostic impact of monocyte percentage and extranodal involvement in classical hodgkin lymphoma: A multicenter real-world study of 547 chinese patients. (2026/03/23) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. An Asymptomatic 42-Year-Old Woman With Randomly Distributed Semicalcified Pulmonary Nodules. (2026/03/10) ♡
• The prognostic utility of a combined PNI-HB immunonutritional index in CD19 CAR T-cell therapy for relapsed/refractory non-Hodgkin lymphoma. (2026/03/06) ♡
• Prognostic Value of the CALLY Index in Diffuse Large B-Cell Lymphoma: Linking Inflammation, Nutrition, and Tumor Biology. (2026/03/05) ♡
• Type 2 diabetes and risk of non-Hodgkin lymphoma and multiple myeloma: a pooled analysis. (2026/03/03) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Understanding the factors influencing quality of life among survivors of Non-Hodgkin lymphoma after completing primary treatment: a systematic review. (2026/03/03) ♡
• Expression of Programmed Death Ligand 1 (PD-L1) in Classical Hodgkin Lymphoma- Study from a Tertiary Care Cancer Centre in South India. (2026/03/01) ♡
• Characteristics and Outcomes of Patients with Hodgkin Lymphoma with Paraneoplastic Manifestations. (2026/03/01) ♡
• Primary Soft Tissue DLBCL Mimicking Sarcoma. (2026/03/01) ♡
• A Population-Based Matched Cohort Study of Extra-Digestive Cancer Incidence and Mortality in Individuals With and Without Inflammatory Bowel Disease. (2026/03/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.